Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Valproic acid treatment may cause hair loss due to reduced biotinidase activity.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Valproic acid can cause hair loss, but information on hair color change is not detailed.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Flutamide treatment showed no significant changes in mice vaginal mucosa.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.